Modern Synthesis

Modern Synthesis is a London-based biotechnology company developing a new class of bio-based materials by combining bacterial nanocellulose with conventional textile processes. Its patent-pending microbial weaving platform engineers bacteria to convert agricultural sugars into nanocellulose, which is grown around a yarn scaffold to create composite materials that can replace petrochemical- and animal-derived textiles such as leather. The company has worked with brands including GANNI on commercial applications and positions its technology as a drop-in-compatible alternative for fashion, footwear, and automotive supply chains.

Company Facts

  • Headquarters: London, United Kingdom
  • Founded: 2019
  • Employees: 27
  • Type: startup
  • Website: https://www.modernsynthesis.com
  • Industries: Biomaterials, Biofabrication, Materials Science, Sustainable Textiles, Synthetic Biology, Biotechnology

Key People at Modern Synthesis

  • Ioannis Zampetakis — Head of Science
  • Sarah West Young — Head of Growth
  • Patricia Ahufinger — Vice President of Operations
  • Ben Reeve — Co-Founder & CTO
  • Jen Keane — Co-Founder & CEO